The Board of Directors of OPTUS Pharmaceutical Co., Ltd. has authorized a buyback plan on September 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,130 KRW | -0.33% | +1.83% | +15.23% |
1st Jan change | Capi. | |
---|---|---|
+15.23% | 72.42M | |
+14.56% | 9.15B | |
-13.94% | 4.9B | |
+48.58% | 4.46B | |
+14.10% | 4.09B | |
+19.66% | 2.49B | |
-25.55% | 2.17B | |
+18.39% | 2.1B | |
-39.57% | 1.89B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A131030 Stock
- News OPTUS Pharmaceutical Co., Ltd.
- OPTUS Pharmaceutical Co., Ltd. authorizes a Buyback Plan.